Company Overview
Snapshot
Founded in December 2022 by Co-founder & CEO Gal Harth, FlowMD operates with 1–10 employees. The company is currently in a Pre-Funding stage.
Business overview
FlowMD develops a mobile and professional biofeedback platform designed to help individuals manage anxiety, panic, stress, sleep issues, and nervous-system regulation. Its core technology guides users through short breathing sessions, leveraging phone camera and movement signals to provide real-time heart-rate and breathing feedback. The platform also supports therapists and wellness professionals by offering a remote biofeedback workflow, client referrals, training, and a professional dashboard to monitor client progress between sessions. FlowMD operates within the Health Tech & Life Sciences sector, specifically focusing on Digital Healthcare and Digital Therapeutics, serving both B2C and B2B markets.
Log in to access full profile ›Company Intelligence Q&A
- What is FlowMD's primary focus?
- FlowMD focuses on providing a mobile and professional biofeedback platform for mental health, helping users manage anxiety, stress, sleep issues, and nervous system regulation through guided breathing sessions.
- When was FlowMD founded?
- FlowMD was founded in December 2022.
- Who is the CEO of FlowMD?
- Gal Harth is the Co-founder and CEO of FlowMD.
- What technology does FlowMD utilize?
- FlowMD utilizes a mobile application that uses the phone camera and movement signals to provide real-time heart rate and breathing feedback during biofeedback sessions.
- What markets does FlowMD serve?
- FlowMD serves both direct consumers and healthcare professionals, including therapists and wellness practitioners, within the Digital Healthcare and Digital Therapeutics markets.